| Hey Trader, Just a few days ago I alerted my PVA members to a brand new opportunity on a biopharm stock that is squarely in the buy zone.
After declining for the past 10 weeks, the stock moved right into the meat of the high-volume area marked out on our roadmap. This is the area where big institutional buyers have been stepping in for years… And it presents one heck of an opportunity for traders like us. Now as you can see by the bell-shaped curve in the volume profile on the right-hand side of the chart, the acceptance area engulfs the range between $85 and $100. Of course, anything can happen during election season. But I anticipate this stock to bounce at least to the top of this range… and hopefully beyond. Now if you're not quite sure what this volume profile "roadmap" is and why it's such a powerful tool for identifying high-probability opportunities… And tell you how you can get your hands on this ticker today! Yours for more precise trading,
Ross Givens |
| Market Traders Daily |
| Disclaimer: Futures, forex, stock, and options trading are not appropriate for all traders. There is a substantial risk of loss associated with trading these markets. Losses can and will occur. No system or methodology has ever been developed that can ensure returns or against losses. No representation or implication is being made that using any of these methodologies or systems will generate returns or ensure against losses. Global Profits System International |
No comments:
Post a Comment